🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $PLAY and executed a BUY strategy, securing a +29.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$ARWR

Arrowhead Pharmaceuticals

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 06, 2026 🌙 Close🌐 Website🏛️ NASDAQ📁 Healthcare🏭 Biotechnology
AVG HISTORICAL GAP0.00%
MAX GAP RECORD0.00%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY0.0%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL